Ameloblastoma epidemiology and demographics

Revision as of 02:57, 24 October 2017 by Mmir (talk | contribs) (Category)
Jump to navigation Jump to search

Ameloblastoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ameloblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ameloblastoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ameloblastoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ameloblastoma epidemiology and demographics

CDC on Ameloblastoma epidemiology and demographics

Ameloblastoma epidemiology and demographics in the news

Blogs on Ameloblastoma epidemiology and demographics

Directions to Hospitals Treating Ameloblastoma

Risk calculators and risk factors for Ameloblastoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

The incidence of ameloblastoma is approximately 1.96, 1.20, 0.18, and 0.44 per 100,000 for black males, black females, white males, and white females respectively worldwide. Ameloblastoma affects men and women equally. There is no racial predilection to the ameloblastoma. Ameloblastoma usually occur in middle age group i.e. 20-40 years: the median age at diagnosis is 39 years. [1][2]

Epidemiology and Demographics

Ameloblastoma although rare, is the most common odontogenic tumor accounting for 1% of all oral tumors and around 18% of all odontogenic tumors. They are rare in children. Approximately, 8.7% - 15% of all ameloblastomas occur in children. Ameloblastoma occurs in all areas of jaws, but the mandible is the most commonly affected area i.e. more than 80% of cases are seen here. Within the mandible, the area commonly involved is near the angle of the mandible in the region of the 3rd molar tooth (the molar angle ramus area). It is involved three times more commonly than are anterior and premolar regions combined. Although benign, it is a locally aggressive neoplasm with a high rate of recurrence.[1]

Incidence

The annual incidence of ameloblastoma is approximately 1.96, 1.20, 0.18, and 0.44 per 100,000 for black males, black females, white males, and white females respectively worldwide.

Gender

Ameloblastoma affects men and women equally. Although, women tend to be 4 years younger than men when tumors first occur and tumors appear to be larger in females.[2]

Race

There is no racial predilection to the ameloblastoma. However, there is conflicting evidence on the incidence rates in different races. Although some reports claim an increased incidence of ameloblastoma in black individuals, a large study identifies Asians as the population with greatest number of affected patients. Ameloblastoma is by far the most common unequivocal odontogenic neoplasm in all ethnic groups, representing approximately 1% of head and neck neoplasms in Europe and the USA, some studies claim that it has the highest incidence in Afro-Caribbean populations.[3]

Age

They are slow growing and tend to present in the 3rd to 5th decades of life. Ameloblastoma usually occur in middle age group i.e. 20-40 years: the median age at diagnosis is 39 years. Maxillary and extraosseous ameloblastoma commonly affects individuals in a slightly older age group while unicystic and granular cell ameloblastoma occur in a younger age group. The average age of unicystic ameloblastoma is 10.8 years.

References

  1. 1.0 1.1 Ameloblastoma. Wikipedia(2015) https://en.wikipedia.org/wiki/Ameloblastoma Accessed on December 25, 2015
  2. 2.0 2.1 Toledo-Pereyra LH, Bergren CT (1987). "Liver preservation techniques for transplantation". Artif Organs. 11 (3): 214–23. PMID 3304226.
  3. Morgan, Peter R. (2011). "Odontogenic tumors: a review". Periodontology 2000. 57 (1): 160–176. doi:10.1111/j.1600-0757.2011.00393.x. ISSN 0906-6713.

Template:WH Template:WS